Journal article
Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
Abstract
OBJECTIVE: The influence of biological sex on human immunodeficiency virus (HIV) antiretroviral treatment outcome is not well described in HIV-hepatitis C (HCV) coinfection.
METHODS: We assessed patients' clinical outcomes of HIV-HCV coinfected patients initiating antiretroviral therapy attending the Ottawa Hospital Immunodeficiency Clinic from January 1996 to June 2008.
Authors
Emery J; Pick N; Mills EJ; Cooper CL
Journal
Patient Preference and Adherence, Vol. 4, No. 0, pp. 97–103
Publisher
Taylor & Francis
Publication Date
May 13, 2010
DOI
10.2147/ppa.s9949
ISSN
1177-889X